Donor age(years) (MeanąSD) | 26.9ą6.5 |
Recipient age(years) (MeanąSD) | 46.3ą8.2 |
Donor gender males females |
114(68.3%) 53 (31.7%) |
Recipient gender males females |
147 (88%) 20 (12%) |
BMI of donor (MeanąSD) | 25.2ą3.4 |
Child class A B C |
9(5.4%) 50 (29.9%) 108 (64.7 %) |
MELD score (MeanąSD) | 16.1ą4.2 |
Co morbidity | 61(36.5%) |
Portal HTN | 160(95.8%) |
Bl. Group Compatible Identical |
48(28.7%) 119(71.3%) |
Graft type Right lobe Left lobe |
159(95.2%) 8(4.8%) |
HV anastomosis Single Multiple |
115 (68.9%) 52 (31.1%) |
PV anastomosis Single Multiple |
155 (92.8%) 12(7.2%) |
HA anastomosis Single Multiple |
160 (95.8%) 7 (4.2%) |
Preoperative PVT | 19 (11.4%) |
Actual graft weight (MeanąSD) | 819.4ą172.1 |
Actual GRWR | 1.04ą0.2 |
Cold ischemia time (min) (MeanąSD) | 74.9ą52.1 |
Warm ischemia time (min) (MeanąSD) | 52.1ą16.05 |
Time of arterial anastomosis (min) (MeanąSD) | 67.8ą34.8 |
Intraoperative blood transfusion (units) | 7.03ą7.4 |
Intraoperative plasma transfusion(units) | 8.3ą8.9 |
Duration of operation (hours) (MeanąSD) | 13.08ą3.2 | Hospital stay ( postoperative)( days) (MeanąSD) | 22.7ą16.05 |
Immunosuppression regimen Regimen including FK Regimen including Cyclosporine Regimen including Sirolomus |
144(86. 2%) 51(30.5 %) 19 (11.4%) |